The past few years, and particularly recent months, have brought an onslaught of regulatory headwinds for the biopharma industry. Managing...
pharma
“Addressing both geopolitical exposure and the life sciences’ own internal market forces will be essential to building a resilient supply...
Donald Trump has hinted at a tariff reprieve for pharmaceutical companies, which are braced for fresh sector-specific import taxes as...
While some may have oversold the technology in recent years, virtual reality (VR) is still a growing industry. Society hasn’t...
